ATE353366T1 - Nukleinsäure und protein, genannt 158p1d7, für die behandlung und erkennung von blasenkrebs und anderen krebsarten - Google Patents

Nukleinsäure und protein, genannt 158p1d7, für die behandlung und erkennung von blasenkrebs und anderen krebsarten

Info

Publication number
ATE353366T1
ATE353366T1 AT01964345T AT01964345T ATE353366T1 AT E353366 T1 ATE353366 T1 AT E353366T1 AT 01964345 T AT01964345 T AT 01964345T AT 01964345 T AT01964345 T AT 01964345T AT E353366 T1 ATE353366 T1 AT E353366T1
Authority
AT
Austria
Prior art keywords
cancer
protein
called
types
detection
Prior art date
Application number
AT01964345T
Other languages
English (en)
Inventor
Mary Faris
Rene S Hubert
Arthur B Raitano
Daniel E H Afar
Elana Levin
Pia M Challita-Eid
Aya Jakobovits
Original Assignee
Agensys Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agensys Inc filed Critical Agensys Inc
Application granted granted Critical
Publication of ATE353366T1 publication Critical patent/ATE353366T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT01964345T 2000-08-22 2001-08-22 Nukleinsäure und protein, genannt 158p1d7, für die behandlung und erkennung von blasenkrebs und anderen krebsarten ATE353366T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22709800P 2000-08-22 2000-08-22
US28273901P 2001-04-10 2001-04-10

Publications (1)

Publication Number Publication Date
ATE353366T1 true ATE353366T1 (de) 2007-02-15

Family

ID=26921162

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01964345T ATE353366T1 (de) 2000-08-22 2001-08-22 Nukleinsäure und protein, genannt 158p1d7, für die behandlung und erkennung von blasenkrebs und anderen krebsarten

Country Status (10)

Country Link
US (6) US6863892B2 (de)
EP (2) EP1854809B1 (de)
AT (1) ATE353366T1 (de)
AU (2) AU2001285210A1 (de)
CA (1) CA2420543C (de)
DE (1) DE60126495T2 (de)
DK (1) DK1854809T3 (de)
ES (2) ES2281437T3 (de)
PT (1) PT1854809E (de)
WO (2) WO2002016593A2 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7358353B2 (en) 2000-08-22 2008-04-15 Agensys, Inc. Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers
CA2420543C (en) * 2000-08-22 2013-04-02 Agensys, Inc. Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers
AU1181802A (en) 2000-09-27 2002-04-08 Curagen Corp Novel proteins and nucleic acids encoding same
WO2002026826A2 (en) * 2000-09-27 2002-04-04 Curagen Corporation Proteins and nucleic acids encoding same
US7223577B2 (en) * 2000-11-17 2007-05-29 Allergan, Inc. Post-translational modifications and Clostridial neurotoxins
EP2343315A3 (de) * 2003-02-10 2011-11-23 Agensys, Inc. Nukleinsäure und entsprechendes Protein mit der Bezeichnung 158P1D7, das sich für die Behandlung und den Nachweis von Blasenkrebs und anderen Krebserkrankungen eignet
US7400642B2 (en) * 2003-08-29 2008-07-15 Samsung Electronics Co., Ltd Apparatus and method for controlling operational states of medium access control layer in a broadband wireless access communication system
AU2004279610B2 (en) * 2003-10-07 2010-02-25 Ingrid Dheur Piscirickettsia salmonis antigens and use thereof
US20110171251A1 (en) * 2004-10-01 2011-07-14 Micael Thiry Piscirickettsia salmonis antigens and use thereof
AU2013200566B2 (en) * 2006-10-17 2014-10-09 Oncotherapy Science, Inc. Peptide vaccines for cancers expressing MPHOSPH1 or DEPDC1 polypeptides
EP2687540A1 (de) 2006-10-17 2014-01-22 Oncotherapy Science, Inc. Peptidvakzinen für MPHOSPH1- oder DEPDC1-Polypeptide exprimierenden Krebs
US20090090696A1 (en) * 2007-10-08 2009-04-09 Cabot Microelectronics Corporation Slurries for polishing oxide and nitride with high removal rates
US8101371B2 (en) * 2007-10-18 2012-01-24 Musc Foundation For Research Development Methods for the diagnosis of genitourinary cancer
AU2008337440B2 (en) * 2007-12-19 2013-05-02 Intervet International B.V. Vaccine antigens from Piscirickettsia salmonis
US20100330113A1 (en) * 2007-12-19 2010-12-30 Intervet International B.V. Vaccine Antigens
US8449512B2 (en) 2010-04-09 2013-05-28 Davinci Biomedical Research Products Inc. Stoma stabilitating device and method
WO2012169911A1 (en) * 2011-06-10 2012-12-13 Auckland Uniservices Limited Peptides, constructs and uses therefor
GB201115910D0 (en) 2011-09-14 2011-10-26 Univ Manchester Peptides
SG10201912773TA (en) 2012-08-23 2020-02-27 Agensys Inc Antibody drug conjugates (adc) that bind to 158p1d7 proteins
AU2016306527B2 (en) 2015-08-12 2022-03-17 Oncotherapy Science, Inc. DEPDC1-derived peptide and vaccine containing same
CN108489921B (zh) * 2018-05-02 2020-08-11 天津科技大学 一种免双氧水快速检测半胱氨酸的方法

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US33504A (en) * 1861-10-15 Improvement in nozzles for hose-pipes
US335074A (en) * 1886-01-26 jewett
WO1989006692A1 (en) * 1988-01-12 1989-07-27 Genentech, Inc. Method of treating tumor cells by inhibiting growth factor receptor function
US5225538A (en) 1989-02-23 1993-07-06 Genentech, Inc. Lymphocyte homing receptor/immunoglobulin fusion proteins
WO1992000311A1 (en) 1990-06-27 1992-01-09 Princeton University Probes for detecting mutant p53
SE9002480D0 (sv) 1990-07-23 1990-07-23 Hans Lilja Assay of free and complexed prostate-specific antigen
CH686982A5 (fr) 1993-12-16 1996-08-15 Maurice Stroun Méthode pour le diagnostic de cancers.
US5919652A (en) 1994-11-09 1999-07-06 The Regents Of The University Of California Nucleic acid molecules comprising the prostate specific antigen (PSA) promoter and uses thereof
US5783186A (en) * 1995-12-05 1998-07-21 Amgen Inc. Antibody-induced apoptosis
WO1997041255A1 (en) 1996-04-26 1997-11-06 Massachusetts Institute Of Technology Three-hybrid screening assay
US5840501A (en) 1996-10-25 1998-11-24 Bayer Corporation Determination of cPSA
CA2296792A1 (en) 1999-02-26 2000-08-26 Genset S.A. Expressed sequence tags and encoded human proteins
JP2003518920A (ja) 1999-07-02 2003-06-17 カイロン コーポレイション 新規なヒト遺伝子および遺伝子発現産物
EP1074617A3 (de) 1999-07-29 2004-04-21 Research Association for Biotechnology Primers für Synthese von ganzen-Länge cDNS und deren Anwendung
AU2001229340A1 (en) 2000-01-14 2001-07-24 Millennium Pharmaceuticals, Inc. Genes compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
AU2001243142A1 (en) 2000-02-03 2001-08-14 Hyseq, Inc. Novel nucleic acids and polypeptides
US7534417B2 (en) * 2000-02-24 2009-05-19 Agensys, Inc. 103P2D6: tissue specific protein highly expressed in various cancers
US20060003323A1 (en) * 2000-03-01 2006-01-05 John Alsobrook Therapeutic polypeptides, nucleic acids encoding same, and methods of use
CA2407449A1 (en) 2000-04-27 2001-11-01 Smithkline Beecham Corporation Novel compounds
US20040033504A1 (en) * 2001-04-26 2004-02-19 Pankaj Agarwal Novel compounds
AU2001271623A1 (en) 2000-06-30 2002-01-14 Incyte Genomics, Inc. Human extracellular matrix (ecm)-related tumor marker
CA2420543C (en) * 2000-08-22 2013-04-02 Agensys, Inc. Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers
AU2001287022A1 (en) 2000-09-05 2002-03-22 Incyte Genomics, Inc. Secretory molecules
EP2298789B1 (de) 2000-09-08 2012-03-14 Schering Corporation Gene von Säugetiere, und damit verbundene Reagentien, Methoden
WO2002026826A2 (en) 2000-09-27 2002-04-04 Curagen Corporation Proteins and nucleic acids encoding same
AU1181802A (en) * 2000-09-27 2002-04-08 Curagen Corp Novel proteins and nucleic acids encoding same
CA2423677A1 (en) * 2000-10-04 2002-04-11 Curagen Corporation Novel proteins and nucleic acids encoding same and antibodies directed against these proteins
US20040029114A1 (en) * 2001-01-24 2004-02-12 Eos Technology, Inc. Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer
EP1425302A2 (de) 2001-01-24 2004-06-09 Protein Design Labs Methoden zur diagnose von brustkrebs sowie methoden zur identifizierung von substanzen, die brustkrebs beeinflussen
US20020192678A1 (en) 2001-02-09 2002-12-19 Huei-Mei Chen Genes expressed in senescence
AU2002322280A1 (en) 2001-06-21 2003-01-21 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
US20040076955A1 (en) 2001-07-03 2004-04-22 Eos Biotechnology, Inc. Methods of diagnosis of bladder cancer, compositions and methods of screening for modulators of bladder cancer
EP1430112A4 (de) 2001-09-24 2005-06-15 Nuvelo Inc Neue nukleinsäuren und polypeptide
WO2003035831A2 (en) 2001-10-22 2003-05-01 Exelixis, Inc. Lrrcaps as modifiers of the p53 pathway and methods of use

Also Published As

Publication number Publication date
WO2002016598A3 (en) 2003-01-23
WO2002016593A3 (en) 2002-12-27
US6863892B2 (en) 2005-03-08
AU2001286699A1 (en) 2002-03-04
US20030017466A1 (en) 2003-01-23
ES2281437T3 (es) 2007-10-01
US20030166526A1 (en) 2003-09-04
CA2420543C (en) 2013-04-02
DE60126495D1 (de) 2007-03-22
EP1854809A1 (de) 2007-11-14
US20030199470A1 (en) 2003-10-23
HK1110876A1 (en) 2008-07-25
WO2002016598A2 (en) 2002-02-28
EP1311675B1 (de) 2007-02-07
AU2001285210A1 (en) 2002-03-04
US20050227253A1 (en) 2005-10-13
PT1854809E (pt) 2012-12-26
DE60126495T2 (de) 2007-11-29
ES2395524T3 (es) 2013-02-13
US20060018917A1 (en) 2006-01-26
WO2002016593A2 (en) 2002-02-28
US20030207835A1 (en) 2003-11-06
EP1311675A2 (de) 2003-05-21
EP1854809B1 (de) 2012-10-03
CA2420543A1 (en) 2002-02-28
DK1854809T3 (da) 2013-01-21

Similar Documents

Publication Publication Date Title
DE60126495D1 (de) Nukleinsäure und protein, genannt 158p1d7, für die behandlung und erkennung von blasenkrebs und anderen krebsarten
TR200400149T2 (tr) Tümörlerin teşhisi ve tedavisi için mikroorganizmalar ve hücreler
ATE165980T1 (de) Nukleinsaürefragmente, die mannose bindende fragmente vom menschlichen mannosebindenden protein kodieren
BR9808509A (pt) Composições e métodos para o tratamento e diagnóstico do câncer de mama
EP1706423B8 (de) Therapeutische und diagnostische anti-hsp 70-antikörper
CY1109029T1 (el) Νουκλεϊνικο οξυ και αντιστοιχη πρωτεϊνη ονομαζομενη 85p1b3 χρησιμα στην αγωγη και τον εντοπισμο του καρκινου
WO2002014361A3 (en) NUCLEIC ACIDS AND CORRESPONDING PROTEINS ENTITLED 83P2H3 AND CaTrF2E11 USEFUL IN TREATMENT AND DETECTION OF CANCER
DE69932922D1 (de) Verwendung von alkansäuren-enthaltenden zusammensetzungen zur behandlung von nagelpilz-erkrankungen
WO2004072263A3 (en) Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers
WO2003080800A3 (en) Prevention and treatment of disease using angiogenesis-and/or tumor antigens
ATE392474T1 (de) 84p2a9: prostata- und testis-spezifisches protein das hohe expression in prostatakrebs aufweist
WO2003020954A3 (en) 205p1b5 in treatment and detection of cancer
DE60139150D1 (de) Zusammensetzungen und verfahren zur therapie und diagnose von lungenkrebs
WO2002014501A3 (en) Nucleic acids and corresponding proteins entitled phor1-a11 and phor1-f5d6 useful in treatment and detection of cancer
DE60230051D1 (de) Nukleinsäure und entsprechendes protein mit der bezeichnung 121p2a3 zur behandlung und zum nachweis von krebs
WO2001075022A3 (fr) Nouveau polypeptide, eucaryon acetyl transferase humaine 12, et polynucleotide codant pour ce polypeptide
WO2001075026A3 (fr) Nouveau polypeptide, eucaryote acetyl transferase humaine 10, et polynucleotide codant pour ce polypeptide
WO2001075011A3 (en) A novel polypeptide, cytochrome human constitution protein 10 and the polynucleotide encoding the polypeptide
RU2000127063A (ru) Способ лечения дегенеративно-дистрофических поражений позвоночника у детей
WO2001075036A3 (fr) Nouveau polypeptide, immunophiline humaine 14, et polynucleotide codant pour ce polypeptide
WO2001075034A3 (en) A novel polypeptide, human peroxydase protein 15 and the polynucleotide encoding the polypeptide
WO2001075035A3 (en) A novel polypeptide, human peroxydase protein 9 and the polynucleotide encoding the polypeptide
RU99109141A (ru) Способ лечения псориаза
WO2001075043A3 (en) A novel polypeptide, dna-dependent human protein kinase 9 and the polynucleotide encoding the polypeptide
WO2001079431A3 (fr) Nouveau polypeptide, proteine humaine d'interaction 15 avec la proteine huntingtine, et polynucleotide codant pour ce polypeptide

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1311675

Country of ref document: EP